Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 05 Mar 2024 for Cyteir Therapeutics, Inc., €5,020.
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
David G. Gaiero: trading record in brief
David G. Gaiero discloses dealings in 2 companies, chiefly Cyteir Therapeutics, Inc. and Wave Life Sciences Ltd. In total, 10 filings cover trades dated from 3 February 2020 to 4 March 2024.
The open-market record consists of 1 sale worth €4,109, with no purchase. Besides market trades, the filings include 1 share grant and 8 option exercises.
The newest entry dates from 5 March 2024: an option exercise of €3,699, in Cyteir Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David G. Gaiero
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,239 shares@ US$1.685.3% of flowCommon StockSEC:0001209191-24-004439:0
1,620 shares@ US$1.682.6% of flowCommon StockSEC:0001209191-23-058610:0
52,584 shares@ US$1.6884.9% of flowCommon StockSEC:0001209191-23-056425:0
4,100 shares@ US$1.686.0% of flowCommon StockSEC:0001209191-23-007528:0
5,000 shares@ US$1.497.2% of flowCommon StockSEC:0001209191-23-007536:0
5 of 5 declarations
